(Total Views: 80)
Posted On: 07/09/2024 8:56:10 AM
Post# of 122
$INBS Intelligent Bio Solutions Strengthens UK Market Position with Addition of Key Manufacturing Accounts
https://www.globenewswire.com/news-release/20...ounts.html
NEW YORK, July 09, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"
, a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced the addition of several key accounts in the UK manufacturing sector. This announcement follows recent successes in the warehouse and logistics, transport and infrastructure, and retail sectors as the Company's growth momentum continues.
Recent additions to INBS' customer account portfolio include three major manufacturers, each with unique needs and challenges in maintaining workplace safety. A leading automotive components manufacturer with five sites and 1,200 employees has transitioned from third-party urine testing to the Intelligent Fingerprinting Drug Screening System. The previous method involved long wait times for testing call-outs, which delayed critical safety checks. The company has improved testing and operational efficiency by adopting INBS' instant, on-site fingerprint drug testing. Other account additions include a major packaging manufacturer operating four sites with approximately 900 employees and a well-known beverage manufacturer with two sites and 350 employees. Neither company had previously implemented drug testing protocols. Both companies required a quick, non-invasive method to test staff, and fingerprint drug testing provided the ideal solution, allowing for rapid and reliable testing.
Doug Heath, Vice President of Global Sales at INBS, commented, "Our Intelligent Fingerprinting Drug Screening System provides businesses within the manufacturing sector with an efficient and non-invasive method to enhance workplace safety, ensuring that safety-critical staff are fit for duty at all times. We are proud to support these companies in their commitment to maintaining a safe and productive work environment by providing an effective and easy-to-implement solution."
Drug‐ and alcohol‐related impairment in the workplace has been linked to an increased risk of injury for workers. The Health and Safety Executive (HSE) reported that the UK manufacturing sector had a statistically significant rate of non-fatal workplace injuries, with 1,740 injuries per 100,000 workers in 2022/23. These figures highlight the need for effective drug screening methods to ensure worker safety.
INBS' innovative solution addresses workplace safety concerns by providing accurate, on-the-spot testing. The Intelligent Fingerprinting Drug Screening System screens for common drugs of abuse, including cannabis, opiates, cocaine, and methamphetamine, using sweat from the fingertips. This method offers a non-invasive, rapid alternative to traditional testing methods, ensuring employees are fit for duty.
https://www.globenewswire.com/news-release/20...ounts.html
NEW YORK, July 09, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"
, a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced the addition of several key accounts in the UK manufacturing sector. This announcement follows recent successes in the warehouse and logistics, transport and infrastructure, and retail sectors as the Company's growth momentum continues. Recent additions to INBS' customer account portfolio include three major manufacturers, each with unique needs and challenges in maintaining workplace safety. A leading automotive components manufacturer with five sites and 1,200 employees has transitioned from third-party urine testing to the Intelligent Fingerprinting Drug Screening System. The previous method involved long wait times for testing call-outs, which delayed critical safety checks. The company has improved testing and operational efficiency by adopting INBS' instant, on-site fingerprint drug testing. Other account additions include a major packaging manufacturer operating four sites with approximately 900 employees and a well-known beverage manufacturer with two sites and 350 employees. Neither company had previously implemented drug testing protocols. Both companies required a quick, non-invasive method to test staff, and fingerprint drug testing provided the ideal solution, allowing for rapid and reliable testing.
Doug Heath, Vice President of Global Sales at INBS, commented, "Our Intelligent Fingerprinting Drug Screening System provides businesses within the manufacturing sector with an efficient and non-invasive method to enhance workplace safety, ensuring that safety-critical staff are fit for duty at all times. We are proud to support these companies in their commitment to maintaining a safe and productive work environment by providing an effective and easy-to-implement solution."
Drug‐ and alcohol‐related impairment in the workplace has been linked to an increased risk of injury for workers. The Health and Safety Executive (HSE) reported that the UK manufacturing sector had a statistically significant rate of non-fatal workplace injuries, with 1,740 injuries per 100,000 workers in 2022/23. These figures highlight the need for effective drug screening methods to ensure worker safety.
INBS' innovative solution addresses workplace safety concerns by providing accurate, on-the-spot testing. The Intelligent Fingerprinting Drug Screening System screens for common drugs of abuse, including cannabis, opiates, cocaine, and methamphetamine, using sweat from the fingertips. This method offers a non-invasive, rapid alternative to traditional testing methods, ensuring employees are fit for duty.
(0)
(0)
